Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.

Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy. Clin Cancer Res. 2017 Dec 15; 23(24):7543-7549.

View in: PubMed

subject areas

Adult
Aged
Cisplatin
Disease-Free Survival
Drug-Related Side Effects and Adverse Reactions
Epirubicin
Esophageal Neoplasms
Female
Fluorouracil
Genetic Association Studies
Genotype
Germ-Line Mutation
Humans
Male
Middle Aged
Neoplasm Proteins
Perioperative Period
Polymorphism, Single Nucleotide
Stomach Neoplasms
Thymidylate Synthase
United Kingdom

authors with profiles

MASSIMO RUGGE